KATHERINE ARENSMEYER: Open Payments
NPI 1609106517 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 52 payments from 30 companies in 2025. Trend: 2023 $1,289 · 2024 $1,925 · 2025 $1,719
Food & beverage: $1,676Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $288 |
| Janssen Biotech, Inc. | 4 | $217 |
| ABBVIE INC. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| PFIZER INC. | 4 | $87 |
| Astellas Pharma US Inc | 3 | $78 |
| Gilead Sciences, Inc. | 3 | $68 |
| BeOne Medicines USA, Inc. | 2 | $59 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Incyte Corporation | 2 | $52 |
Products named: RYBREVANT, Enhertu, EPKINLY, JEMPERLI, TEVIMBRA, Trodelvy, CARVYKTI, KEYTRUDA.
Industry payments across PA — which companies pay providers there.
